Brief: Enorama Pharma CEO Daniel Schröder Resigns
04/11/2025 14:01
Nov 4 (Reuters) - Enorama Pharma AB ERMA.ST: DANIEL SCHRÖDER RESIGNS AS CEO OF ENORAMA PHARMA BENGT JÖNSSON APPOINTED INTERIM CEO, ARA ABRAHAMIAN NEW CHAIRMAN Source text: ID:nWkrbsJ9zj Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO